Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metastatic pheochromocytoma and paraganglioma.

European journal of clinical investigation - 1 Sept 2015

Angelousi Anna, Kassi Evanthia, Zografos Georgios, Kaltsas Gregory

Abstract excerpt

BACKGROUND: Metastatic pheochromocytomas (PCs) and paragangliomas (PGLs) are rare neuroendocrine tumours with a strong genetic background. DESIGN: We searched the PubMed database through February 2015 to identify studies characterizing metastatic PCs/PGLs as well as currently established and evolving therapies. RESULTS: Large size tumours (> 5 cm), PASS score > 6 and Ki-67 labelling index > 3% are the most robust...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Fluorodeoxyglucose F18
Share to Multimodal Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Paraganglioma

Share to Pheochromocytoma

Share to Positron-Emission Tomography

Share to Radiopharmaceuticals

Share to Succinate Dehydrogenase

Source

Identifiers

PMID: 26183460
DOI: 10.1111/eci.12495

Genes

SDHB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metastatic pheochromocytoma and paraganglioma.PMID 26183460Read ↗

Metastatic paraganglioma.Semantic proximity Read ↗

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSemantic proximity Read ↗

Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.Semantic proximity Read ↗

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted TherapiesSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of OriginSemantic proximity Read ↗

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task ForceSemantic proximity Read ↗

The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented PerspectivesSemantic proximity Read ↗

The Molecular Classification of Pheochromocytomas and Paragangliomas: Discovering the Genomic and Immune Landscape of Metastatic DiseaseSemantic proximity Read ↗

Pheochromocytoma: A Clinicopathologic and Molecular Study of 390 Cases From a Single Center.Semantic proximity Read ↗

Pathology and genetics of phaeochromocytoma and paragangliomaSemantic proximity Read ↗

Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual PatientsSemantic proximity Read ↗

Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and ImagingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.